Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ronrydellon Dec 03, 2014 10:28am
282 Views
Post# 23189637

RE:RE:RE:RE:RE:Drip, Drip, Drip etc

RE:RE:RE:RE:RE:Drip, Drip, Drip etcRead the previous post to which I responded...I was asked what my multimillionaire inventor friend of the diabetic pump thought about the stock and I responded. This isn't me wining. I personally believe that like so many bio tech stocks this one will go,the way of most. However RVX has got the cash to let it play out.

The public shell that I referred to is a common financing technique as it's cheaper than going public. I think that one dollar a share price will,interest part of the holdings of the 200K holder that's been around for ten years.

I hope RVX succeeds but when stacked up against all the other opportunities out there I'm not betting my farm on this deal or its management. I'm also not interested in anymore high risk/high reward deals.

The self agrandizing multi year posts of SF have proved entertaining with some well written prose but at the end of of the day..it's the the share price that tells the story and he's come up short in the space over and over again.

My shares are all available for,a buck for,whoever wants them!
Bullboard Posts